The Board of Directors of Redsense Medical AB (publ) has decided to convene an Extraordinary General Meeting on Thursday 24 April 2025. Further details regarding the proposal for the Extraordinary General Meeting are set out in the notice, which is presented in its entirety below.

The notice will be published in Post- och Inrikes Tidningar and on the company's website in the coming days.

NOTICE OF EXTRA GENERAL MEETING IN Redsense Medical AB (publ)

Redsense Medical AB (publ) will hold an Extraordinary General Meeting on Thursday 24 April 2025 at 4.00 p.m. at Grand Hotell Halmstad, Stationsgatan 44, 302 45 Halmstad. Registration starts at 3.30 p.m.

Right to attend and notification to the company

Shareholders wishing to attend the meeting shall:

1. be registered as a shareholder in the share register maintained by Euroclear Sweden AB on Monday 14 April 2025,
2. notify the company of their intention to participate no later than Wednesday 16 April 2025.

Notification of participation shall be made by e-mail to info@redsensemedical.com or in writing to the company at the address Storgatan 36, 302 43 Halmstad. When giving notice of attendance, please state your name or company name, personal identification number or organisation number, address and daytime telephone number. For notification of assistants, the notification procedure as above applies.

Nominee REGISTERED SHARES

Shareholders whose shares are registered in the name of a nominee must, in order to be entitled to participate in the meeting, have their shares registered in their own name through a nominee, so that they are registered in the share register maintained by Euroclear Sweden AB on Monday 14 April 2025. Such registration may be temporary (so-called voting rights registration) and is requested by the nominee in accordance with the nominee's routines in such time in advance as the nominee determines. Voting rights registrations made by the relevant nominee no later than Wednesday, 16 April 2025 will be taken into account in the preparation of the share register.

Proxy and proxy FORMS

Anyone who is not present in person at the meeting may exercise their voting rights at the meeting by proxy with a written, signed and dated proxy form. Forms of proxy are available on the company's website, www.redsensemedical.com. The proxy form can also be obtained from the company at the above address. If the proxy is issued by a legal entity, a copy of the registration certificate or equivalent authorisation document for the legal entity must be attached. A proxy may not be older than one year unless a longer period of validity is specified in the proxy form, but no longer than five years. To facilitate admission to the meeting, the proxy form, registration certificate and other authorisation documents should be received by the company well in advance of the meeting.

Proposed agenda

1. Opening of the Meeting
2. Election of the Chairman of the Meeting
3. Preparation and approval of the voting list
4. Approval of the agenda
5. Election of one or two persons to approve the minutes
6. Examination of whether the Meeting has been duly convened
7. Resolution on the number of Directors
8. Election of Director
9. Closing of the meeting

RESOLUTIONS PROPOSED BY THE NOMINATION COMMITTEE

Due to unforeseen events in early 2025, the Company does not have a quorate Board of Directors, which is why the Board has called this Extraordinary General Meeting. The Nomination Committee intends to present shortly a proposal for a new permanent Board of Directors to be elected at the Annual General Meeting, which is planned to be held at the end of May 2025. The Board of Directors for this Extraordinary General Meeting consists of Susanne Olauson (Chairman) and Martin Roos, both of whom are elected for the period until the next Annual General Meeting.

Against this background, the Nomination Committee proposes the following.

Item 2 - Election of the Chairman of the Meeting

The Board of Directors proposes Susanne Olauson or, if she is prevented from attending the person designated by the Board of Directors to chair the meeting.

Item 7 - Resolution on the number of Directors

The Nomination Committee proposes that the Board of Directors, for the period until the end of the next Annual General Meeting, shall consist of three Board members elected by the Annual General Meeting without deputies.

Item 8 - Election of Director

The Nomination Committee proposes the election of the company's CFO, Peter Larsson, as a new member for the period until the end of the next Annual General Meeting.

Documents

All documents required by the Swedish Companies Act will be available at the Company and on the Company's website and will be sent immediately and free of charge to shareholders who so request and provide their postal address. The documents will also be available at the meeting.

Information AT THE MEETING

Shareholders are reminded of their right to request information from the Board of Directors and the Managing Director at the meeting in accordance with the Swedish Companies Act.

Processing of personal data

For information on how your personal data is processed, please see:

https://www.euroclear.com/dam/ESw/Legal/Integritetspolicy-bolagsstammor-svenska.pdf.

_____________

Halmstad April 2025

Redsense Medical AB (publ)

The Board of Directors

For further information, please contact:

Sebastien Bollue, CEO

Telephone: +46 72-171 1264

E-mail: sebastien.bollue (at) redsensemedical.com

Redsense Medical AB (publ), 556646-4862